63 parallel-programming-"DIFFER"-"Mohammed-VI-Polytechnic-University" Fellowship positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
are available from 1 July 2025 to 30 June 2026 in the first instance. Based in the interdisciplinary Living Systems Institute, the successful applicants will join a world-leading programme of investigations
-
together University of Helsinki research across nine different units, to address challenges relating to the production, processing, distribution and use of food and drug products without compromising human
-
embryonic stem cells to different tissue types as 2D and 3D gastruloids Technical expertise in advanced live imaging Technical expertise in molecular biology Excellent track record of writing papers as
-
play in advancing the Crick’s mission and shaping our culture! We are bold. We make space for creative, dynamic and imaginative ideas and approaches. We’re not afraid to do things differently. We
-
Masters of TCM, National “Ten Thousand Talent Program” Leading Talents, Chief Scientist of the 973 Program, and National Famous Doctors of TCM etc. Currently, ZCMU employs 1,600 faculty and staff, and among
-
mission and shaping our culture! We are bold. We make space for creative, dynamic and imaginative ideas and approaches. We’re not afraid to do things differently. We are open. We’re highly collaborative and
-
are bold. We make space for creative, dynamic and imaginative ideas and approaches. We’re not afraid to do things differently. We are open. We’re highly collaborative and interactive, and make sure our
-
collaboration across different disciplines. This project aims to develop and refine molecular diagnostic assays, metagenomic sequencing approaches, and computational tools to improve the detection and
-
interdisciplinary approaches in their research program. Excellent written and oral communication skills. To see the complete job description click here . To see more about team/Group Leader click here. About Working
-
. Potential projects focus on severe ADRs to a range of different medications. Current priority ADRs include cisplatin-induced ototoxicity, anthracycline-induced cardiotoxicity, COVID-19 vaccine-induced